Clinical trial into puberty blockers paused after ‘new concerns’ from medicines regulator

Lucian Nemoiu

The MHRA will now discuss the concerns, related to the wellbeing of children and young people with gender dysphoria, with trial sponsor King’s College London next week Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice A clinical trial into puberty blockers for children

din zilele anterioare